von Hippel-Lindau peptide vaccine
A cancer vaccine composed of peptides derived from a tumor-associated protein encoded by a mutated Von Hippel-Lindau (VHL) oncogene. VHL peptide vaccine may stimulate a cytotoxic T cell response against tumor cells expressing the VHL tumor-associated protein.
| Synonym: | VHL peptide vaccine VHL Peptides |
|---|---|
| NSC code: | 900100 |